10.1007/s12020-012-9629-8 [DOI] [PubMed] [Google Scholar] 253.Riaz, M
Eat Colourfully Cruciferous vegetables, citrus, and berries are rich in Vitamin C, sulfur compounds, and phytonutrients that naturally fuel glutathione synthesis
The effect of antioxidant supplementation on fatigue during exercise: potential role for NAD+(H)
Directions: Once or twice daily, apply 1 dropper of A.G.E
Selective MC1R agonist primary receptor target MC1R with secondary activity at MC3R, MC4R, MC5R Two targeted modifications vs native -MSH Nle and D-Phe enhance metabolic stability in experimental systems Linear 13 amino acid structure distinct from cyclic MT-2 (Melanotan II) with different receptor selectivity profile Activates cAMP/PKA signaling cascade via MC1R in cell-based research systems Studied extensively in melanogenesis, melanocortin receptor pharmacology, and comparative ligand selectivity research FDA-approved pharmaceutical equivalent (Scenesse/Afamelanotide) provides extensive published clinical literature for reference Lyophilized format ensures stability and reproducibility across experimental runs Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background MT-1 (Afamelanotide) was developed in the 1980s at the University of Arizona by Mac Hadley and Victor Hruby as part of a program investigating synthetic -MSH analogs for melanocortin receptor research
Folic Acid Methylfolate (L-5-methylfolate, sold as Metafolin and Quatrefolic) is a form of folate promoted for use by people with common genetic mutations that affect the MTHFR enzyme
